A carregar...
Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics
OBJECTIVE: Exemestane is a third-generation aromatase inhibitor used in the treatment of breast cancer in postmenopausal women. Reduction to form 17-dihydroexemestane and subsequent glucuronidation to exemestane-17-O-glucuronide is a major pathway for exemestane metabolism. The goal of this study wa...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3076703/ https://ncbi.nlm.nih.gov/pubmed/20697310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32833b04af |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|